NDSI
SLDB icon

Newman Dignan & Sheerar Inc’s Solid Biosciences SLDB Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,002
Closed -$7 – 199
2022
Q3 		$7 Buy
+1,002
New +$10.1K ﹤0.01% 184
2022
Q1 		– Sell
-802
Closed -$21K – 214
2021
Q4 		$21K Buy
802
+134
+20% +$4.09K 0.01% 200
2021
Q3 		$24K Buy
+668
New +$28.4K 0.01% 192

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newman Dignan & Sheerar Inc's SLDB Position: Q4 2022 in Review

Newman Dignan & Sheerar Inc sold out of Solid Biosciences (SLDB) in Q4 2022, closing a stake of 1,002 shares — an estimated $7 sold.

Newman Dignan & Sheerar Inc first reported a position in SLDB in Q3 2021 and held it in 3 quarters. The position peaked at $24K in Q3 2021. 35 funds tracked by Wall St. Rank hold SLDB as of Q4 2022.

  • Newman Dignan & Sheerar Inc reported no remaining Solid Biosciences position as of Q4 2022 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 1,002 Solid Biosciences shares in Q4 2022, an estimated $7.
  • Newman Dignan & Sheerar Inc first reported a position in Solid Biosciences in Q3 2021 and held it in 3 quarters.
  • Newman Dignan & Sheerar Inc's Solid Biosciences position peaked at $24K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2022.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q4 2022, filed 20 Jan 2023.